Relative lung and systemic bioavailability of sodium cromoglycate inhaled products using urinary drug excretion post inhalation

Biopharmaceutics and Drug Disposition

Volumn 23, Issue 4, 2002, Pages 159-163

  Aswania, Osama ^a   Chrystyn, Henry ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Inhalation; Sodium cromoglycate; Urinary excretion

Indexed keywords

CROMOGLYCATE DISODIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; METERED DOSE INHALER; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; BIOLOGICAL AVAILABILITY; CROMOLYN SODIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUNG; MALE; TIME FACTORS;

EID: 0036572841     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.308     Document Type: Article

References (25)

1. Deposition of pressurised suspension aerosols inhaled through extension devices
2. The fate of inhaled terbutaline
3. Use of pressurised aerosols by asthmatic patients
4. Clinical use of dry powder systems
5. Patient error in the use of bronchodilator metered aerosols
6. Large volume plastic spacers in asthma
7. Spacer devices used with metered dose inhalers: Breakthrough or gimmick?
8. Targeting drug delivery to the lungs by inhalation
9. Critical aspects of the function of inspiratory flow driven inhalers
10. Drug delivery to the respiratory tract using dry powder inhalers
11. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion
12. Determination of the relative bioavailability of salbutamol to the lung following inhalation
13. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices
14. Dry powder inhaler are bioequivalent to metered-dose inhalers, A study using a new urinary albuterol (salbutamol) assay technique
15. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung
16. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation and avoiding multiple actuation of drug
17. Multiple actuation of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range
18. In vitro performance of plastic spacer devices
19. Development and validation of an ion-pair chromatographic method for the quantification of sodium cromoglycate in urine, following inhalation
20. Effect of powder inhaler design on drug deposition in the respiratory-tract
21. In vivo evaluation of the new multiple dose powder inhaler and the Rotahaler using the gamma scintigraphy
22. The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration
23. Inhalational drug delivery from seven different spacer devices
24. Improvement of pressurised aerosol deposition with Nebuhaler spacer device
25. Relative bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device